National Health (Pharmaceutical Benefits) Regulations (Amendment)

Overview

Statutory Rules 1959 No. 4, enacted under the authority of the National Health Act 1953-1958, addresses the administration and regulation of pharmaceutical benefits provided by the Commonwealth. The Regulations were introduced to amend and update the National Health (Pharmaceutical Benefits) Regulations, reflecting the evolving landscape of medical treatments and the need for precise oversight. Enacted by the Governor-General in and over the Commonwealth of Australia, these Regulations aim to ensure that the pharmaceutical benefits are appropriately prescribed and supplied, while maintaining the integrity of the national health scheme. The amendments include modifications to the list of pharmaceutical benefits and the criteria for their prescription, thereby improving the efficiency and effectiveness of the health care system.

Scope and Application

These Regulations under the National Health Act 1953-1958, made by the Governor-General in accordance with the advice of the Federal Executive Council, apply specifically to pharmaceutical benefits within the Commonwealth of Australia. They concern the amendments to the National Health (Pharmaceutical Benefits) Regulations, impacting entities involved in the supply and prescription of pharmaceuticals, including medical practitioners authorised by the Director-General. The Regulations modify the list of specified diseases or purposes for which certain pharmaceutical benefits can be prescribed, the procedures for writing prescriptions, and the conditions under which pharmaceutical benefits can be supplied before the surrender of a written prescription. The Regulations also revise the schedules to list new pharmaceuticals and conditions for which these pharmaceuticals can be prescribed. The changes are effective from 1 February 1959, and further application or modification of these provisions can occur through subordinate instruments as deemed necessary by the relevant authorities.

Key Provisions

The Regulations, made under the National Health Act 1953-1958, introduce amendments to the National Health (Pharmaceutical Benefits) Regulations, effective from 1 February 1959. Regulation 11, concerning the pharmaceutical benefits that may be prescribed for specified diseases or purposes, is amended to reduce the list of diseases or purposes by omitting figures 48, 49, 50, and 51 from sub-regulation (2), and inserting 49 instead (Regulation 2). Regulation 17, concerning the writing of prescriptions, is amended to omit the figures 21 and 111 from sub-regulation (3) and to include the provision that prescriptions can be written by an officer of the Commonwealth Department of Health who is a medical practitioner and authorised by the Director-General (Regulation 3). Regulation 21, which pertains to the supply of pharmaceutical benefits before the surrender of a written prescription, is amended to allow such supply by an authorised officer of the Commonwealth Department of Health who is a medical practitioner (Regulation 4). These Regulations impose several obligations and requirements on the parties governed by them. Medical practitioners authorised by the Director-General of the Commonwealth Department of Health are now permitted to write prescriptions for pharmaceutical benefits that may be prescribed for specified diseases or purposes, as well as to supply pharmaceutical benefits before the surrender of a written prescription. Additionally, certain pharmaceutical items listed in the First Schedule are amended to reflect updated or corrected information. The Second Schedule is also amended to include new diseases or purposes for which certain pharmaceutical benefits may be prescribed, and to remove others that are no longer applicable. The Regulations do not explicitly outline any offences, penalties, or consequences for breaches. However, given the context of the National Health Act 1953-1958 and the nature of the amendments, it can be inferred that any non-compliance with the Regulations may result in administrative, civil, or criminal consequences, depending on the severity and intent of the breach. The maximum penalties for such breaches would likely be in accordance with the provisions of the National Health Act 1953-1958 and any relevant subsidiary legislation or common law principles.